Jagsonpal Good Will from 2010 to 2024

JAGSNPHARM   636.65  9.80  1.52%   
Jagsonpal Pharmaceuticals' Good Will is decreasing with slightly volatile movements from year to year. Good Will is predicted to flatten to 0.00. Good Will is an intangible asset that arises when Jagsonpal Pharmaceuticals Limited acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors. View All Fundamentals
 
Good Will  
First Reported
2012-09-30
Previous Quarter
0.0
Current Value
96.9 M
Quarterly Volatility
19.3 M
 
Yuan Drop
 
Covid
Check Jagsonpal Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jagsonpal Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 14.6 M, Interest Expense of 7.7 M or Total Revenue of 1.8 B, as well as many indicators such as . Jagsonpal financial statements analysis is a perfect complement when working with Jagsonpal Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement various Jagsonpal Pharmaceuticals Technical models . Check out the analysis of Jagsonpal Pharmaceuticals Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Jagsonpal Stock

Jagsonpal Pharmaceuticals financial ratios help investors to determine whether Jagsonpal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jagsonpal with respect to the benefits of owning Jagsonpal Pharmaceuticals security.